Qube Research & Technologies (QRT)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-242,056
| Closed | -$3.81M | – | 4349 |
|
2024
Q1 | $3.81M | Buy |
242,056
+122,296
| +102% | +$1.92M | 0.01% | 1187 |
|
2023
Q4 | $1.93M | Buy |
119,760
+44,004
| +58% | +$710K | ﹤0.01% | 1315 |
|
2023
Q3 | $964K | Sell |
75,756
-25,791
| -25% | -$328K | ﹤0.01% | 1420 |
|
2023
Q2 | $1.43M | Buy |
+101,547
| New | +$1.43M | 0.01% | 1093 |
|
2023
Q1 | – | Sell |
-164,226
| Closed | -$2.69M | – | 3064 |
|
2022
Q4 | $2.69M | Buy |
164,226
+42,710
| +35% | +$700K | 0.01% | 778 |
|
2022
Q3 | $2.25M | Buy |
121,516
+52,522
| +76% | +$972K | 0.01% | 836 |
|
2022
Q2 | $907K | Buy |
+68,994
| New | +$907K | 0.01% | 1135 |
|
2020
Q1 | – | Sell |
-5,304
| Closed | -$330K | – | 1773 |
|
2019
Q4 | $330K | Buy |
+5,304
| New | +$330K | 0.01% | 1181 |
|